Drugplain

NuvaRing .015 mg/d

etonogestrel and ethinyl estradiol · INSERT, EXTENDED RELEASE · Advanz Pharma (US) Corp.

No Recall HistoryCurrently in Shortage
Plain English

NuvaRing is a insert, extended release containing etonogestrel and ethinyl estradiol at .015 mg/d, taken vaginal. Manufactured by Advanz Pharma (US) Corp..

Key Facts

Brand Name
NuvaRing
Generic Name
etonogestrel and ethinyl estradiol
NDC Code (Product)
59212-146
Manufacturer
Advanz Pharma (US) Corp.
Strength
.015 mg/d
Dosage Form
INSERT, EXTENDED RELEASE
Route
VAGINAL
Marketing Status
Application #
NDA021187
Drug Class
Estrogen [EPC]; Progestin [EPC]
Marketing Start
05/19/2025

Recall History

No Recall History

Frequently Asked Questions

What is NuvaRing used for?

NuvaRing contains etonogestrel and ethinyl estradiol. It is a insert, extended release taken vaginal. Consult your doctor for specific uses.

Is NuvaRing a controlled substance?

NuvaRing is not classified as a controlled substance by the DEA.

What is the generic name for NuvaRing?

The generic name for NuvaRing is etonogestrel and ethinyl estradiol. There are 9 other brand versions of etonogestrel and ethinyl estradiol.

What is the NDC code for NuvaRing .015 mg/d?

The NDC (National Drug Code) for NuvaRing .015 mg/d is 59212-146, listed by Advanz Pharma (US) Corp..